FDA Approves Dovato for Teens Living With HIV

WEDNESDAY, April 10, 2024-- The U.S. Food and Drug Administration has approved Dovato (dolutegravir/lamivudine) for adolescents living with HIV.The approval is for the treatment of HIV-1 infection in adolescents aged 12 years and older (weighing...